Overexpression of fibroblast growth factor receptor 3 (FGFR3) has been shown to drive oncogenesis in a subset of patients with multiple myeloma. However, epithelial cancers — such as bladder ...
Hosted on MSN11mon
For Advanced Bladder Cancer, The Drug Balversa Is Now FDA Approved– A Promising Therapy For People With Specific MutationsBalversa works by targeting genetic mutations called FGFR3 and FGFR2. FGFR stands for fibroblast growth factor receptors. These are proteins that give cells their orders to grow and divide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback